Skip to main content

Table 1 Patient characteristics

From: CD39 and LDHA affects the prognostic role of NLR in metastatic melanoma patients treated with immunotherapy

Characteristics

n = 78, n (%)

Age (years), median (range)

61 (27–91)

Gender:

 • Female

41 (53)

 • Male

37 (47)

Melanoma AJCC VII stage:

 • Stage IV

74 (94)

 • Stage IIIC

4 (5)

 • Stage IIIB

1 (1)

Brain metastases at baseline

18 (23)

BRAF status:

 • Wild-type

59 (76)

 • Mutation

16 (21)

 • NA

3 (3)

M category:

 • M0

3 (4)

 • M1a

11 (14)

 • M1b

10 (13)

 • M1c

54 (69)

LDH:

 • High

26 (33)

 • Normal

34 (44)

 • NA

18 (23)